Pharmaceutical Anti-Counterfeiting Technologies: Market Analysis and Forecasts 2015-2025

LONDON, January 14, 2015 /PRNewswire/ --

Pharmaceutical Anti-counterfeiting Technologies - new study showing you trends, R&D progress, and predicted revenues
Where's the pharmaceutical anti-counterfeiting technologies market heading? Visiongain's brand new report shows you potential revenues to 2025, assessing data, trends, opportunities and prospects there.

Our 242-page report provides 126 tables, charts, and graphs. Discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market, submarket and national level. You will see financial results, interviews, trends, opportunities, and revenue predictions. Much opportunity remains in this growing market.

Forecasts from 2015-2025 and other analyses show you commercial prospects
Besides revenue forecasting to 2025, our new study provides you with recent results, growth rates, and market shares. There you find original analyses, with business outlooks and developments. Discover qualitative analyses (including SWOT and STEP Analysis), company profiles and commercial developments.

Read the full transcripts of six exclusive expert opinion interviews from industry specialists informing your understanding and allowing you to assess prospects for investments and sales, including:
- Dave Coons, VP of Advanced Markets and Technology; Laurie Eldridge-Shanaman, Director, Global Healthcare Practice; Clive Hohberger; Previously VP of Technology Development at Zebra Technologies
- Ryon Packer, Chief Marketing Officer and General Manager at Authentix
- Dr Michael Hogan, Vice President of Life Sciences at Applied DNA Sciences
- Mike Messmer, General Manager at NovaVision
- Dr Fred Jordan, Chief Executive Officer at AlpVision
- Spokesperson from a leading anti-counterfeiting technologies company based in the US

To see a report overview please email Sara Peerun on [email protected]

Discover sales predictions for the world market and submarkets
Along with revenue prediction for the overall world market, you see forecasts to 2025 for these five submarkets:
• Barcodes
• RFID
• Holograms/OVD
• Taggants
• Other anti-counterfeiting technologies

With our investigation you gain business research and analysis with submarkets sales predictions and discussions. You find analysis of competition, as well as commercial drivers and restraints affecting each submarket. See what's likely to achieve the most success.

You gain competitive advantages by understanding the dynamics, opportunities and challenges facing the pharmaceutical anti-counterfeiting technologies market. As well as finding technologies that will likely to achieve the most success.

What are the prospects in the leading regions and countries?
In addition to analyses of the overall world market, you discover individual revenue forecasts for 8 regional markets to 2025:
• US
• EU5
• Japan
• China
• India
• Brazil
• Russia
• Mexico
• Rest of the World

There will be growth in established and developing pharma markets. Our analyses show that the US, China, India, Mexico and Brazil, in particular, will continue to achieve high revenue growth to 2025. Developments worldwide, mandatory government requirements and rising awareness of counterfeit drugs will influence the market.

Many opportunities exist for security companies developing anti-counterfeiting technologies. You can assess the industry's future - hear about developments and find their significance in our analytical report.

Leading companies and potential for market growth
Overall world revenue for pharmaceutical anti-counterfeiting technologies will reach $3.4bn in 2015, our work forecasts. We predict strong revenue growth from 2015 to 2025. Rising consumption of counterfeit drugs, government regulatory mandates and FDA initiatives, technological advancements and the rapid growth of the RFID submarket will drive sales to 2025.

Our work shows you which companies hold the greatest potential. See profiles of 16 leading companies, including these:
• 3M
• Alien Technology
• AlpVision
• Angstrom Technologies
• Authentix
• Avery Dennison
• Colorcon
• Covectra
• Everest Holovisions
• InkSure Technologies
• Intermec
• Multi Packaging Solutions
• ThermoFisher Scientific
• TruTag Technologies
• UPM Raflatac
• Zebra Technologies

A company profile gives you the following information:
• Discussion of a company's activities and outlook
• Recent financial results
• Profiles of key anti-counterfeiting technologies
• Assessment of recent developments - mergers and acquisitions (M&A), new products, and collaborations, including alliances, partnerships and joint ventures

Discover capabilities, progress, and commercial prospects, helping you stay ahead.

To see a report overview please email Sara Peerun on [email protected]

What issues will affect the pharmaceutical anti-counterfeiting technologies market?
Our new report discusses issues and events affecting the pharmaceutical anti-counterfeiting technologies market. You will find discussions, including qualitative analyses:
• Increasing demand for pharmaceutical anti-counterfeiting technologies due to increasing cases of counterfeit drugs
• Government requirements on serialisation in key national markets
• Protection of brand name and revenues
• Cost of implementing anti-counterfeiting technologies
• Dilution impact on supply chains
• Online market for pharmaceutical drugs

You will see discussions of technological, commercial, political and economic matters, with emphasis on the competitive landscape and business outlooks.

How the Pharmaceutical Anti-counterfeiting Technologies: Market Analysis and Forecasts 2015-2025 report helps you
In summary, our 242-page report gives you the following knowledge:
• Revenues forecast to 2025 for the world pharmaceutical anti-counterfeiting technologies market and 5 submarkets - discover the industry's prospects, finding promising places for investments and revenues
• Revenue forecasts to 2025 for the leading 8 regional markets - US, EU5, Japan, China, India, Brazil, Russia, Mexico and Rest of the World
• Assessment of 16 leading companies - hear about products, results and strategies, and recent developments
• Discussion of what stimulates and restrains companies and the market - you assess challenges and strengths
• Understanding of competition and opportunities - you see what affects that industry, learning what shapes its future
• Prospects for established firms and those seeking to enter the market - you explore needs, practices and outlooks for success
• View interviews with market experts - gain exclusive market insights

You will find quantitative and qualitative analyses with independent predictions. You will receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else
We give independent analysis from our primary and secondary research. You will receive business intelligence found only in our study, seeing where prospects are lucrative and growth is likely.

With our report you are less likely to fall behind in knowledge or miss opportunity. See how you could benefit your research, analyses, and decisions, saving you time and getting you recognition for commercial insight.

Discover technological and commercial prospects from 2014 by ordering now
Visiongain's study is for everybody needing commercial analyses for the pharmaceutical anti-counterfeiting technologies market and leading companies. You find data, trends and predictions. Please order our report now.

To request an exec summary of this report please email Sara Peerun at [email protected] or call Tel: +44 (0) 20 7336 6100

Or click on https://www.visiongain.com/Report/1360/Pharmaceutical-Anti-counterfeiting-Technologies-Market-Analysis-and-Forecasts-2015-2025

Companies Listed on this report 

3M
Adhesives Research
Ahura Scientific
Alien Technology
AlpVision
Amerisource
AmerisourceBergen (Amgen)
AND Automation
Angstrom Technologies
Angstrom Technologies
Apoteket
Applied DNA Sciences
ARmark Authentication Technologies
AstraZeneca
Authentix
Avery Dennison
Axway
Baxter
Cal Sierra
Camdata
Cardinal Health
Cellular Bioengineering
CFC International
Colorcon
Cortegra
Covectra
DataDot Technology
DataTrace DNA
Digital China
Domino
DuPont
Everest Holovisions
Genentech
GIS
GlaxoSmithKline (GSK)
Hart Systems
Hoffmann-La Roche
Hologram Industries
Holomex
Holovisions
Honeywell
Image Solutions
Impinj
Ingenia Technology
Inksure Technologies
Intermec Technologies
International Ink Company
Johnson & Johnson (J&J)
Kodak
LaserLock
Life Technologies
McKesson
Menasha Corporation
MicroTag Temed
Microtrace Solutions
Millennium Pharmaceuticals
Motorola
Multi Packaging Solutions (formerly Chesapeake)
Nanotech Security Corp
Neri Labels
Novartis
Novavision
OEP Technologie BV
Pacific Holographics
Pera Innovation
Pfizer
ROC IT Solutions
Roche
Sanofi
SciClone
Shanghai Ruizhang Investment
SICPA
Siemens
Smartrac
Spectra Systems Corporation
Sun Chemical
Symbol Technologies
Systech
Tagsys RFID
Texas Instruments
The Carlyle Group
ThermoFisher Scientific
TruTag Technologies
UPM Raflatac
UPM-Kymmene Corporation
Voxtel
Webscan
WuXi PharmaTech
Zebra Technologies

Other Organisations Mentioned in this Report
Agência Nacional de Vigilância Sanitária (ANVISA)
American Academy of Paediatrics (AAP)
Anti-counterfeiting Drug Research Institute (IRACM)
Anti-counterfeiting Group (ACG)
Australian Therapeutic Goods Administration (TGA)
British Medicines and Healthcare Products Regulatory Agency (MHRA)
Canadian Anti-counterfeiting Network (CACN)
Centre for Healthcare Supply Chain Research
China Anti-Counterfeiting Technology Association (CATA)
China Food and Drug Administration (CFDA)
China Trade Association for Anti-Counterfeiting (CTAAC)
China's Ministry of Public Security (MPS)
Chinese Quality Brands Protection Committee (QBPC)
Council of Europe
Drugs Standard Control Organisation (DSC)
Europe's Medicrime Convention Council
European Alliance for Access to Safe Medicines (EAASM)
European Directorate for the Quality of Medicines and Healthcare (EDQM)
European Federation of Pharmaceutical Industries and Associations (EFPIA)
European Medicines Agency
Federal System of Control of Medication (SNCM)
Food and Drug Administration (FDA)
Healthcare Distribution Management Association (HDMA)
Holograms Manufactures Association of India (HOMAI)
Indian Directorate General of Foreign Trade (DGFT)
International Anti-counterfeiting Coalition (IACC)
International Authentication Association (IAA)
International Criminal Police Organization (INTERPOL)
International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)
International Hologram Manufacturers Association (IHMA)
International Organization for Standardization (ISO)
International Policy Network (IPN)
Japanese Pharmaceutical Manufacturers Association (JPMA)
Loughborough University
Massachusetts Institute of Technology (MIT)
National Agency for Food and Drug Administration and Control (NAFDAC)
National Associations of Boards of Pharmacy (NABP).
National Health Surveillance Agency (ANVISA)
OpSec Security
Organisation for Economic Co-operation and Development (OECD)
Partner for Safe Medicines (PSM)
Patients Association
Pharmaceutical Research and Manufacturers of America (PhRMA)
Pharmaceutical Security Institute (PSI)
Royal Pharmaceutical Society of Great Britain (RPSGB)
Russian Economic Development Ministry
Russian Ministry of Health
South Dakota School of Mines and Technology
University of South Dakota
US Centre for Safe Internet Pharmacies (CSIP)
World Customs Organization (WCO)
World Health Organization (WHO)
World Intellectual Property Organisation (WIPO)

To see a report overview please email Sara Peerun on [email protected]

SOURCE Visiongain